Schonfeld Strategic Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Sell |
52,340
-6,012
| -10% | -$68.5K | ﹤0.01% | 1408 |
|
|
2025
Q1 | $693K | Sell |
58,352
-344,603
| -86% | -$4.09M | ﹤0.01% | 1328 |
|
|
2024
Q4 | $7.59M | Buy |
402,955
+47,353
| +13% | +$892K | 0.04% | 351 |
|
|
2024
Q3 | $7.99M | Sell |
355,602
-76,687
| -18% | -$1.72M | 0.05% | 296 |
|
|
2024
Q2 | $9.02M | Buy |
432,289
+170,127
| +65% | +$3.55M | 0.06% | 329 |
|
|
2024
Q1 | $3.85M | Buy |
+262,162
| New | +$3.85M | 0.03% | 614 |
|
|
2022
Q1 | – | Sell |
-7,600
| Closed | -$220K | – | 2601 |
|
|
2021
Q4 | $220K | Buy |
+7,600
| New | +$220K | ﹤0.01% | 1613 |
|